GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $232,000 | +26.8% | 5,494 | +15.4% | 0.00% | +100.0% |
| Q4 2016 | $183,000 | -7.6% | 4,761 | +3.9% | 0.00% | 0.0% |
| Q3 2016 | $198,000 | -0.5% | 4,584 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $199,000 | +5.9% | 4,584 | -1.1% | 0.00% | +100.0% |
| Q1 2016 | $188,000 | +21.3% | 4,634 | +20.9% | 0.00% | 0.0% |
| Q4 2015 | $155,000 | -89.7% | 3,834 | -90.2% | 0.00% | -91.7% |
| Q3 2015 | $1,501,000 | +0.7% | 39,034 | +9.1% | 0.01% | +9.1% |
| Q2 2015 | $1,491,000 | -7.0% | 35,788 | +3.0% | 0.01% | -8.3% |
| Q1 2015 | $1,604,000 | +247.2% | 34,761 | +221.3% | 0.01% | +300.0% |
| Q4 2014 | $462,000 | +5.7% | 10,820 | +13.8% | 0.00% | 0.0% |
| Q3 2014 | $437,000 | -6.6% | 9,509 | +8.7% | 0.00% | 0.0% |
| Q2 2014 | $468,000 | +31.5% | 8,750 | +31.4% | 0.00% | +50.0% |
| Q1 2014 | $356,000 | +39.1% | 6,658 | +38.7% | 0.00% | 0.0% |
| Q4 2013 | $256,000 | +412.0% | 4,799 | +380.4% | 0.00% | – |
| Q3 2013 | $50,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |